52
Views
18
CrossRef citations to date
0
Altmetric
Drug Profile

Dienogest: an oral progestogen for the treatment of endometriosis

Pages 5-15 | Published online: 10 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (6)

Yasemin Kizilkaya, Mujde Can Ibanoglu, Sadiman Kıykac Altinbas & Yaprak Engin-Ustun. (2022) A prospective study examining the effect of dienogest treatment on endometrioma size and symptoms. Gynecological Endocrinology 38:5, pages 403-406.
Read now
Michele Vignali, Gaia Maria Belloni, Giuliana Pietropaolo, Allegra Barbasetti Di Prun, Valeria Barbera, Stefano Angioni & Ida Pino. (2020) Effect of Dienogest therapy on the size of the endometrioma. Gynecological Endocrinology 36:8, pages 723-727.
Read now
Thomas Strowitzki, Thomas Faustmann, Christoph Gerlinger, Ulrike Schumacher, Christiane Ahlers & Christian Seitz. (2015) Safety and tolerability of dienogest in endometriosis: pooled analysis from the European clinical study program. International Journal of Women's Health 7, pages 393-401.
Read now
Rossella E Nappi, Marco Serrani & Jeffrey T Jensen. (2014) Noncontraceptive benefits of the estradiol valerate/dienogest combined oral contraceptive: a review of the literature. International Journal of Women's Health 6, pages 711-718.
Read now
Helen Schneck, Xiangyan Ruan, Harald Seeger, Michael A. Cahill, Tanja Fehm, Alfred O. Mueck & Hans Neubauer. (2013) Membrane-receptor initiated proliferative effects of dienogest in human breast cancer cells. Gynecological Endocrinology 29:2, pages 160-162.
Read now

Articles from other publishers (12)

Kasiani Papadimitriou, Panagiotis Anagnostis & Dimitrios G. Goulis. 2022. Polycystic Ovary Syndrome. Polycystic Ovary Syndrome 297 314 .
Klaas Heinemann, Bruno Imthurn, Lena Marions, Christoph Gerlinger, Kerstin Becker, Sabine Moehner & Thomas Faustmann. (2020) Safety of Dienogest and Other Hormonal Treatments for Endometriosis in Real-World Clinical Practice (VIPOS): A Large Noninterventional Study. Advances in Therapy 37:5, pages 2528-2537.
Crossref
I. V. Kuznetsova. (2019) Individual choice of hormonal contraceptive. Medical alphabet 1:1, pages 6-14.
Crossref
L. V. Adamyan, K. N. Arslanyan, E. I. Kharchenko & O. N. Loginova. (2019) Modern trends in the treatment of endometriosis. Problemy reproduktsii 25:6, pages 58.
Crossref
T. S. Divakova & A. S. Podgornaya. (2017) INDIVIDUALIZATION OF MANAGEMENT OF PATIENTSWITH ENDOMETRIOSIS OF THE UTERUS BASED ON THE USEOF LEVONORGESTREL-CONTAINING INTRAUTERINE SYSTEMAND HYSTERORESECTOSCOPIC ENDOMETRIAL ABLATION. Health and Ecology Issues:4, pages 22-27.
Crossref
M. I. Yarmolinskaya & M. S. Florova. (2017) The possibility of treatment with dienogest 2 mg in patients with genital endometriosis. Problemy reproduktsii 23:1, pages 70.
Crossref
Maria I Yarmolinskaya, Elena I Rusina, Armine R Khachaturyan & Margarita S Florova. (2016) Clinical picture and diagnosis of genital endometriosis. Journal of obstetrics and women's diseases 65:5, pages 4-21.
Crossref
A. E. Protasova, E. N. Vandeeva & N. S. Kuzmina. (2016) Is endometriosis a benign disease? Modern controversial aspects of endometriosis-associated ovarian tumors. Problemy reproduktsii 22:5, pages 98.
Crossref
Adolf E. Schindler. (2014) The “newer” progestogens and postmenopausal hormone therapy (HRT). The Journal of Steroid Biochemistry and Molecular Biology 142, pages 48-51.
Crossref
Christoph Gerlinger, Thomas Faustmann, Jeffrey J Hassall & Christian Seitz. (2012) Treatment of endometriosis in different ethnic populations: a meta-analysis of two clinical trials. BMC Women's Health 12:1.
Crossref
Christine Klipping, Ingrid Duijkers, Ageeth Remmers, Thomas Faustmann, Christian Zurth, Stefan Klein & Barbara Schuett. (2013) Ovulation‐Inhibiting Effects of Dienogest in a Randomized, Dose‐Controlled Pharmacodynamic Trial of Healthy Women. The Journal of Clinical Pharmacology 52:11, pages 1704-1713.
Crossref
Xiangyan Ruan, H. Seeger & A.O. Mueck. (2012) The pharmacology of dienogest. Maturitas 71:4, pages 337-344.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.